Bicara Therapeutics Inc. Common Stock (NASDAQ:BCAX) Q1 2026 Earnings Call Transcript May 11, 2026
Bicara Therapeutics Inc. Common Stock misses on earnings expectations. Reported EPS is $-0.93 EPS, expectations were $-0.64.
Operator: Good day, and thank you for standing by. Welcome to the Bicara Therapeutics First Quarter 2026 Earnings Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your...
